Skip to main content
MapleLMS Implementation
Conferences and Meetings 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I

203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I

Short name: 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I
Course start date: 11/05/2025

Sections

General
0 activities

Acquired Immunodeficiency Landscapes Via Integrated Noninvasive Viral & Immune Profiling in HIV-Associated Lymphoproliferative Disease
Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations
Elucidation of Human Invariant NKT Cell Immunophenotypes to Provide Insights for Future Universal Donor Derived Cellular Therapeutics
Fluconazole Prophylaxis Significantly Reduce High Risk Invasive Fungal Infection in Immunocompromised Patients Stratified By a Risk Prediction Model
Immune Training Enhances Anti-Viral Responses and Improves Outcomes in Pax5-/+ Mice Susceptible to Chronic Infection
Long-Term Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Patients with Progressive Systemic Sclerosis
Myofibroblast to T-Zone Reticular Cell Ratio Identifies Unicentric Castleman Disease Lymph Nodes
Ras-Associated Autoimmune Lymphoproliferative Disorder: Retrospective Case Series
The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease